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INTRODUCTION Glioblastoma (GBM; World Health Organization grade IV astrocytoma) is the most common and aggressive primary brain tumor in adults, with an average survival of slightly more than 1 year after the initial diagnosis (Ostrom et al., 2014) . Glioma-initiating cells (GICs), a subpopulation of cells inside GBM that could self-renew, differentiate into multiple lineages, and initiate or propagate tumors, have been demonstrated to account for the fatal nature of GBM (Bao et al., 2006; Chen et al., 2012) . Hypoxia is often encountered in solid tumors including GBM, with the hypoxia-inducible factors (HIFs) acting as the key transcriptional modulators that promote multiple processes associated with GBM progression under hypoxic stress (Kaur et al., 2005; Majmundar et al., 2010) . Notably, the hypoxic microenvironment has been revealed to serve as a niche for GICs that promotes the self-renewal and tumorigenic potential of GICs through induction of stem cell markers such as SOX2, POU5F1 (OCT4), and NOTCH1 by HIF1a and HIF2a Soeda et al., 2009) . Multiple aspects of GICs need to be modulated in order
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Glioblastoma is the most common and aggressive primary brain tumor in adults, with glioma-initiating cells (GICs) implicated as being critical for tumor occurrence and recurrence. The hypoxic tumor microenvironment serves as a niche for GICs. Multiple aspects of GICs need to be modulated to reprogram cells to a state favorable for residing in the hypoxic environment and maintaining their distinct biological features. Here, we reveal the HIF-miR-215-KDM1B-mediated signaling required for GIC adaptation to hypoxia through modulating activities of multiple pathways. In the meantime, we uncover an unconventional role of HIF in regulating miRNA biogenesis post-transcriptionally. Therefore, our study provides critical insights into molecular mechanisms underlying the miRNA biogenesis pathway and the essential activities of GICs under hypoxia.
for them to adapt to the hypoxic stress and even benefit from the environment and maintain their distinct biological features.
MicroRNAs (miRNAs) are small, non-coding RNAs of 22 nucleotides, which can regulate diverse biological processes through down-regulation of protein target expression (He and Hannon, 2004) . A number of miRNAs have been demonstrated to be altered by hypoxia to target important oncogenes and tumor suppressors, affecting the hallmarks of tumorigenic processes (Kulshreshtha et al., 2008; Nallamshetty et al., 2013) . The biogenesis of miRNAs initiates with transcription of the miRNA gene. The pri-miRNAs are firstly cropped into the 70-nucleotide pre-miRNA by the microprocessor complex Drosha/DGCR8. Pre-miRNAs are further processed into the miRNA/miRNA* duplex by the Dicer complex. Finally, the 5 0 or 3 0 of the miRNA duplex is incorporated into the RNA-induced silencing complex (RISC) that suppresses the target (Winter et al., 2009) . Multiple steps of miRNA biogenesis are stringently regulated during processes such as tumor progression. For example, various cofactors including Smad and p53 have been shown to associate with the Drosha complex and mediate its processing activity for specific subsets of miRNAs that serve as vital regulators of cancer cell proliferation (Davis et al., 2010; Suzuki et al., 2009) . Accumulating evidence has uncovered the significant role for the post-transcriptional modulations of miRNA processing (Ha and Kim, 2014) .
In this study, we sought to examine roles of miRNAs in regulating GIC adaptation to hypoxia, as well as mechanisms mediating miRNA biogenesis under hypoxia.
RESULTS
MiR-215 Is Induced by Hypoxia in GICs
To identify miRNAs that may mediate the responses of GICs under hypoxia, we conducted a candidate-based screen of miRNAs that have been reported to regulate the processes of cell differentiation and development. We used the cell surface marker CD133 to enrich GICs from patient-derived glioma lines maintained through serial passages in immunocompromised mice as subcutaneous xenografts (Bao et al., 2006; Wang et al., 2014b) . Consistent with previous reports, the CD133 + GICs isolated from two different patient-derived lines (D456MG and 110040) could significantly promote the intracranial tumor progression compared with the CD133 -cells ( Figure S1A ). To identify the miRNAs that may mediate responses to hypoxia, we cultured GICs isolated from these two xenografted lines in 1% O 2 for 6 hr or treated them with the iron chelator desferrioxamine for 3 hr in the initial screen. HIF1a and HIF2a proteins were accumulated, and mRNA levels of the hypoxia-responsive genes SLC2A1 (GLUT1) and ADM were induced after hypoxic treatment (Figures S1B-S1E), indicating a positive hypoxic response in these cells. The expression profile of 88 miRNAs in the GICs cultured under hypoxia compared with normoxia was further determined (Table S1 ). Eleven miRNAs displayed consistent up-regulation in their expression levels under hypoxia (Table S2) . Among these eleven miRNAs, four miRNAs have been shown to play important roles in glioma progression by previous studies, such as miR-218, miR-122, miR-96, and miR-155 (Ling et al., 2013; Mathew et al., 2014; Wang et al., 2014a; Yan et al., 2014) . In agreement with previous findings (Agrawal et al., 2014; Babar et al., 2011; Bruning et al., 2011) , the hypoxic environment also boosted expression of miR-155, miR-129, and miR-134 in the GICs, suggesting a general regulation of these miRNAs by hypoxia.
To assess the potential function of these miRNAs in the GICs cultured under hypoxia, we generated a lentiviral-based sponge construct to attenuate the function of each miRNA (Ebert et al., 2007) . For the seven up-regulated miRNAs that have not been implicated in GBM progression, we successfully introduced individual sponges for five of them into the CD133 + GICs (miR-215, miR-370, miR-134, miR-127, and miR-129) . As displayed in Figure 1A , antagonizing the function of miR-215, rather than other miRNAs, in GICs significantly alleviated GBM progression in mice bearing the intracranial tumor in comparison Figure S1 and Tables S1 and S2. with controls. Therefore, miR-215 emerged as the top candidate for subsequent studies due to its significant impact on tumor progression in mice.
To further validate the expression pattern of miR-215 under hypoxia, we isolated GICs from six additional patient-derived xenografts by the CD133 marker, as well as five freshly isolated patient specimens by a specific culture condition that could significantly enrich the cell population displaying biological properties of GICs but containing both CD133 + and CD133 -GICs (Bhat et al., 2013; Chen et al., 2010) . The expression level of miR-215 was significantly elevated in the majority of GIC samples exposed to hypoxia compared with normoxia ( Figure 1B) . Consistent with the kinetics of immediate response to hypoxia with the 6-hr treatment, expression of miR-215 was also upregulated in GICs cultured under hypoxia for a longer period of time ( Figure 1C ). As an alternative to CD133 to enrich GICs, we utilized another cell surface marker, stage-specific embryonic antigen 1 or CD15 (Son et al., 2009 ) and detected a consistent enhancement of miR-215 expression in CD15 + GICs cultured under hypoxia ( Figure S1F Figure S2 .
induction of miR-215 by hypoxia (Figure S1G) . Importantly, we conducted in situ hybridization (ISH) analyses to examine levels of miR-215 on GBM tissue microarrays and found that a higher level of miR-215 expression was correlated with poor survival ( Figure 1D ). The clinical importance of miR-215 in gliomagenesis is also supported by a recent report that miR-215 expression is positively correlated with poor prognosis in glioma patients (Tong et al., 2015) . In sum, these data strongly indicate that miR-215 is a hypoxia-induced miRNA in GICs, and acts to promote GBM progression probably by mediating the hypoxic responses of GICs.
Biogenesis of miR-215 Is Post-Transcriptionally Enhanced under Hypoxia
In examining the kinetics of miR-215 induction by hypoxia, we found that the expression of miR-194, which resides in the same cluster with miR-215 at chromosomal locus 1q41.1, was not boosted under hypoxia for either 6 hr (Table S1 ) or 24 hr ( Figure S1H ). Since miRNAs of the same clusters are usually expressed together in the same pri-miRNA transcripts (Ventura et al., 2008) , the differential expression pattern between miR-215 and miR-194 in hypoxia prompted us to investigate whether the biogenesis of miR-215 might be enhanced posttranscriptionally.
To examine which biogenesis step of miR-215 might be affected under hypoxia, we measured the expression changes of pri-miR-215, pre-miR-215, and mature miR-215 from GICs isolated from multiple xenografted lines. As shown in Figures  2A and S2A-S2C , induction of mature miR-215 and pre-miR-215 was observed under hypoxia while no significant change in the level of pri-miR-215 was detected, suggesting that processing of miR-215 is regulated at a post-transcriptional step likely through the action of the Drosha complex. As the key transcriptional factors mediating hypoxic response, HIFs are well known to regulate expression of a large number of genes, including miRNA genes. To examine the potential role of HIF in the modulation of miR-215 biogenesis, GICs were transfected with small interfering RNA (siRNA) against HIF1A or scramble control and cultured in 1% O 2 for 24 hr. The mRNA level of HIF1A was knocked down dramatically, and the hypoxiaresponsive gene SLC2A1 (GLUT1) was no longer induced by hypoxia, as expected ( Figure 2B ). HIF1A-siRNA abolished the elevation of pre-miR-215 and mature miR-215 by hypoxia compared with the scramble control ( Figure 2C ). In contrast, the level of unprocessed pri-miR-215 was found to increase under hypoxia when HIF1a was knocked down, suggesting a blockage of the pri-miR-215 processing into pre-miR-215. These results indicate that HIF1a is required for the induction of miR-215 biogenesis under hypoxia.
To further determine whether HIF1a enhances the processing of pri-miR-215 post-transcriptionally, rather than through transcriptional activation, we engineered a luciferase reporter pmirGlo-pri-miR-215, in which the transcription of luciferase/ pri-miR-215 was driven by an exogenous human phosphoglycerate kinase promoter. Since portions of pri-miR-215 are embedded in the 3 0 UTR of the firefly luciferase gene, cleavage of pri-miR-215 by the Drosha complex is expected to destabilize the mRNA of firefly luciferase and in turn to decrease the firefly luminescence. Consequently, the endogenous microprocessor activity could be measured by normalization of the firefly luminescence to the internal control Renilla luminescence. A similar approach has been described to monitor microprocessor activity (Mori et al., 2014; Suzuki et al., 2009) . After transfection of the plasmid into HEK293T cells, expression of the pri-, pre-, and mature miR-215 was measured upon overexpression of the HIF1a protein. An induction of pre-miR-215 and mature miR-215 was observed, while the expression level of the primiR-215 was significantly reduced ( Figure 2D ). Using the same RNAs, induction of mature miR-215 was also detected by Northern blot ( Figure S2D ), indicating that cropping of the pri-miR-215 into pre-miR-215 is enhanced by HIF1a and the endogenous miR-215 promoter is not required for the up-regulation of miR-215. In agreement with the expression profiles of pri-, pre-, and mature miR-215, overexpression of HIF1a accelerated the processing activity of pri-miR-215 by Drosha in a dosedependent manner using the same luciferase reporter pmirGLo-pri-miR-215 ( Figure 2E ).
Taken together, these data indicate that biogenesis of miR-215 is promoted in response to hypoxia at the post-transcriptional step of pri-miR-215 to pre-miR-215, and HIF1a is required for this enhancement in the processing activity of Drosha complex.
HIF1a Promotes miR-215 Biogenesis through
Enhancing Incorporation of the Pri-miR-215 into the Drosha/DGCR8 Complex Hypoxia may regulate miRNA processing through multiple mechanisms. As hypoxia is known to affect gene transcription and protein synthesis (Koumenis et al., 2002; Majmundar et al., 2010) , levels of the microprocessor complexes could be altered by hypoxia, leading to changes in the expression patterns of miRNAs. To test this possibility, we examined the expression profile of the Drosha/DGCR8 and Dicer complexes under hypoxia and found that levels of the Drosha or Dicer complex were not enhanced by hypoxia ( Figures S3A and S3B ), suggesting that induction of miR-215 is not due to up-regulation of Drosha or Dicer expression. This is also supported by the observation that global miRNA elevation was not detected under hypoxia from the miRNA qPCR screen (Table S1 ).
On the other hand, transcription factors such as p53 and Smads have been shown to accelerate subsets of miRNA processing through association with the Drosha complex. We examined the protein levels of p53 and p-Smads and did not detect obvious alteration of their levels in GICs cultured under hypoxia compared with normoxia, indicating that these two pathways are not responsible for the induction of miR-215 processing ( Figure S3C ). To test whether the enhancement of miR-215 biogenesis by HIF1a is the result of a direct interaction between HIF1a and the Drosha complex, we ectopically expressed Drosha and HIF1a in HEK293T cells and found that these proteins could be co-immunoprecipitated ( Figure S3D ). Consistently, HIF1a was accumulated and interacted with Drosha/DGCR8 at the endogenous level in GICs cultured under hypoxia ( Figure 3A) . Interestingly, at the basal level under normoxia, HIF1a was already associated with Drosha/DGCR8. Although there was a dramatic induction of HIF1a protein in cells exposed to hypoxia, the amount of Drosha associated with HIF1a did not increase proportionally, indicating that the larger pool of HIF1a may play multiple functions such as transcriptional stimulation under hypoxia.
The interaction between HIF1a and Drosha/DGCR8 prompted us to determine whether HIF1a might modulate the incorporation of pri-miR-215 into the Drosha complex under hypoxia. RNAchromatin immunoprecipitation (RNA-ChIP) analysis was performed on HEK293T cells transfected with pri-miR-215 and Flag-tagged HIF1a, and an enhanced association of HIF1a with pri-miR-215 was detected ( Figure S3E ). Importantly, endogenous HIF1a also associated with pri-miR-215 in GICs cultured in hypoxia (Figures 3B and S3F) . As a control, there was no significant association between HIF1a and pri-miR-126 or primiR-21, of which the mature form was not altered by hypoxia in GICs. Moreover, the association between pri-miR-215 and Drosha or p68, another component of the Drosha/DGCR8 complex, was increased significantly in GICs cultured under hypoxia, whereas incorporation of other control pri-miRNAs into the Drosha complex was not affected ( Figures 3C, 3D , and S3G), indicating that HIF1a specifically promotes the recruitment of the Drosha/p68 complex to pri-miR-215 to enhance its processing.
As Drosha-mediated biogenesis of miR-215 was enhanced by HIF under hypoxia, we postulated that HIF might play a general role on the processing of a specific group of miRNAs including miR-215. Since the scope of our original qPCR-based miRNA screen was limited, we conducted a small RNA deepsequencing experiment followed by qPCR-based validation in the GICs cultured in hypoxia to identify more miRNAs that may be regulated similarly by HIF on a global scale. The expression profiles of the pri-, pre-, and mature miRNAs were further measured on the candidate miRNAs that were induced by hypoxia in GICs. While expression of most of the miRNAs, such as miR-140, miR-654, and miR-210, started to increase at the transcriptional level by hypoxia ( Figures S3H, S3I , S3L, and S3M), biogenesis of some miRNAs, such as let-7i and miR-1260a, were boosted post-transcriptionally at the step of Drosha-mediated cleavage, in a manner similar as for miR-215 (Figures S3J, S3K, and S3N). Also similarly to miR-215, HIF1a was required for the induction of let-7i biogenesis under hypoxia ( Figure S3O ), through enhancing the recruitment of HIF1a and Drosha/p68 complex on pri-let-7i ( Figures S3P and S3Q ). Since HIF2a shares significant functional similarity with HIF1a, we substituted HIF1a with HIF2a and found it has a similar positive impact on the processing of pri-miR-215 ( Figures S4A-S4D ). To further distinguish the roles of HIF1a and HIF2a, we cultured D456MG GICs under 3% O 2 during which time only HIF2a was accumulated, but did not observe induction of miR-215 ( Figure S4E ). Interestingly, knocking down either HIF1a or HIF2a by small hairpin RNA (shRNA) could abolish the enhancement of miR-215 expression by hypoxia ( Figure S4F ), suggesting that a threshold of combined protein amount of HIF1a and HIF2a might be critical to promote the Drosha-mediated pri-miRNA processing. Together, these results revealed a direct role of HIF1a/HIF2a in mediating the processing of a subset of miRNAs via the Drosha microprocessor complex in GICs' responses to hypoxia. 
Inhibition of miR-215 Suppresses Tumorigenic Abilities of GICs under Hypoxia
MiR-215 has been previously demonstrated to function differentially in different types of cancer. Although overexpression of miR-215 impedes the progression of colon and renal cancer (Jones et al., 2015; Senanayake et al., 2012) , miR-215 is shown to serve as an onco-mir in the development of gastric cancer and hepatoma (Deng et al., 2014; Liu et al., 2014) . Since miR-215 is induced in GICs under hypoxia and attenuation of its function significantly delayed tumor progression ( Figure 1A) , we further examined the role of miR-215 in GICs. Attenuating the function of miR-215 by miR-215-sponge or a specific LNA inhibitor in GICs significantly reduced their growth rate as well as the ability to form neurospheres under hypoxia ( Figures 4A, 4B , and S5A-S5F). In line with the observation in Figure 1A , miR-215-sponge also rendered a significant delay in GBM progression in mice bearing intracranial tumors derived from GICs isolated from the glioma line 110040 ( Figure 4C ). In another experimental setting, we inoculated an equal number of GICs expressing a miR-215-sponge or scramble control intracranially into nude mice and euthanized the two groups of mice on the same day. Histological analysis by H&E staining showed significantly smaller tumor areas in the brain of mice in the miR-215-sponge group (Figures 4D and 4E) . Collectively, these data demonstrate that hypoxia-induced miR-215 is critical for GICs to maintain their growth in culture under hypoxic conditions and to generate tumors in vivo in the intracranial environment.
The Epigenetic Regulator KDM1B Is a Direct Target of miR-215 Potent effects of miR-215 in maintaining the abilities of cell growth and tumor progression in GICs prompted us to explore the downstream effectors of miR-215. To identify downstream targets, we integrated mRNA expression profiling with bioinformatics predictions. As miR-215 is induced by hypoxia, expression of its targets was postulated to be repressed in GICs under hypoxia. Through microarray analysis, we produced a list of genes that were down-regulated in GICs cultured under hypoxia compared with normoxia. Overlapping this list with the candidates generated by three prediction algorithms, we narrowed the potential targets down to 46 genes. Expression of each candidate at the mRNA level was further verified by qPCR in GICs isolated from D456MG and 110040 lines cultured under hypoxia or normoxia conditions. Both miRNA sponge and LNA inhibitor were used to antagonize the function of miR-215. This round of screening yielded 14 putative targets that were consistently downregulated in GICs exposed to hypoxia and up-regulated when miR-215 function was attenuated ( Figure 5A and Table S3 ). To further narrow down the candidates that are most likely to be direct targets of miR-215, we employed RNA-ChIP analysis to identify the mRNAs selectively enriched in the Ago2/RISC complex after miR-215 overexpression ( Figure S6A ). Among the 14 genes, mRNA of KDM1B was detected with the most significant enrichment in miR-215-overexpressing GICs compared with the vector control group ( Figure 5B ). In the meantime, we assessed several targets of miR-215 that were identified previously, including TYMS, ACVR2B, CTNNBIP1, and RB1, but found little or only slight increases in the levels of these mRNAs incorporated into RISC (Figure 5B) , consistent with the previous notion that miRNAs suppress their targets in a context-dependent manner.
Alterations related with histone modification processes in GBM, such as mutations of KDM6A, MLL2, and SETD2, have been reported. These mutations result in disruption of the epigenetic processes and promotion of cancer progression (Sturm et al., 2014) . KDM1B is a FAD-dependent histone demethylase of H3K4me1/2, which might exert its impact on gliomagenesis through modulating the expression of a spectrum of critical genes to reprogram the cellular state to adapt to the hypoxic environment. Therefore, we focused our study on KDM1B and determined the protein level of KDM1B in GICs. Consistent with its mRNA expression profile, the protein level of KDM1B was found to be decreased under hypoxia or increased when miR-215 was suppressed in those cells ( Figure 5C ). In concordance with the expression pattern of miR-215, we did not observe a consistent reduction of KDM1B level by hypoxia in non-GICs isolated from multiple xenografted lines ( Figure S6B ). To further explore whether miR-215 suppresses KDM1B directly through the putative binding sites in the 3 0 UTR of KDM1B gene, a luciferase reporter was employed, in which the 3 0 UTR with wild-type or mutated miR-215 binding sites were embedded downstream of the firefly luciferase (Figure S6C) . Indeed, the luciferase expression was repressed by miR-215 in a dose-dependent manner in HEK293T cells, whereas expression of the luciferase with mutated 3 0 UTR was not altered significantly ( Figure 5D ). In sum, these data support the notion that KDM1B serves as a direct target of miR-215. Data are presented as the mean ± SEM (*p < 0.05, **p < 0.01, ***p < 0.001; ns, not significant). See also Figure S6 and Table S3 .
KDM1B Mediates the Function of miR-215 in Maintaining Biological
Properties of GICs under Hypoxia KDM1B has not been previously implicated in GBM progression or cellular responses to hypoxia. To explore the role of KDM1B in GICs exposed to hypoxia, we ectopically expressed the KDM1B open reading frame (ORF), which could not be suppressed by miR-215 due to lack of the miRNA binding sites. Expression of KDM1B could recapitulate phenotypes of miR-215 knockdown in GICs under hypoxia as demonstrated by the impaired cell growth and neurosphere formation ( Figures 5E-5G and S6D-S6F) . Next, we stably knocked down KDM1B by shRNAs and observed significant augmentation of GICs' ability to form neurospheres ( Figures S6D and S6G ). To further determine whether properties of GICs mediated by miR-215 are attributed to the repression of KDM1B, we attenuated the expression of KDM1B in GICs with shRNAs or Cas9 and single-guide RNAs together with inhibition of miR-215, and found that co-suppression of miR-215 and KDM1B largely rescued the compromised ability of cell growth, neurosphere formation, and tumor progression induced by miR-215 inhibition ( Figures 5E, 5H , and S6H-S6K), suggesting that KDM1B serves as a critical effector downstream of miR-215. Together, these data indicate that miR-215 functions to positively control the biological properties of GICs under hypoxia mainly through suppressing its target KDM1B.
KDM1B Mediates GIC Adaptation to Hypoxia through Modulating Multiple Processes
Large-scale gene profiling and ChIP-ChIP assays were performed in HeLa cells to examine the global effect on genes potentially controlled by KDM1B (Fang et al., 2010) . To identify potential genes and pathways that may be regulated by KDM1B to affect the biological properties of GICs, we conducted an RNA sequencing analysis in the GICs with KDM1B knocked down, and generated a list of genes that might be controlled by KDM1B. Gene ontology analysis was performed separately on this gene list and another list of altered genes under hypoxia that was produced from microarray analysis of the same GICs. The enriched pathways that are overlapped on both lists are considered to be among the likely mediators of KDM1B function during the hypoxic responses in GICs. As shown in Figures S7A and S7B, the analysis revealed that multiple pathways related to cellular response to hypoxia emerged in a prominent pattern, indicating that KDM1B might reprogram GICs for hypoxia adaptation through affecting those pathways.
To confirm whether the genes enriched in those pathways were regulated by the miR-215-KDM1B axis, we subsequently conducted qPCR validation to determine the expression pattern of these genes. Our attention was drawn to three signaling pathways, mainly associated with hypoxic response and glucose metabolism (EPAS1, ADM, NDRG1, SLC2A1, SLC2A3, NDUFA4L2), angiogenesis (VEGF, LAMA5, SER-PINE1), and modification of chondroitin sulfate proteoglycan (CHPF, CHST11). As shown in Figures 6A and 6B , expression of these genes increased when KDM1B was knocked down and was no longer elevated by hypoxia when the function of miR-215 was attenuated, indicating that they serve as downstream targets of miR-215-KDM1B under hypoxia.
To elucidate whether the aforementioned processes contribute to the function of miR-215 and KDM1B in GICs, we assessed multiple biological aspects of these cells when the levels of miR-215 or KDM1B were manipulated. As Glut1 (encoded from SLC2A1) and Glut3 (encoded from SLC2A3) are essential glucose transporters, we first determined the activity of glucose uptake and found that glucose uptake by GICs with suppression of KDM1B was increased significantly ( Figure 6C ). On the other hand, the elevation of glucose uptake in response to hypoxia was abolished in GICs with blockage of miR-215 (Figure 6D) . To further determine whether miR-215 and KDM1B regulate the process of glycolysis, we examined the extracellular acidification rate and observed enhanced production of acid when silencing KDM1B, but reduced acidification when repressing miR-215 in GICs (Figures S7C and S7D) . As a consequence, these data demonstrated that miR-215 activates the anaerobic switch that favors glycolysis during hypoxic response by suppressing KDM1B.
Because VEGF, LAMA5, and SERPINE1 are critical mediators in inducing tumor angiogenesis through regulation of endothelial cell activities including migration, we assessed whether manipulating miR-215 or KDM1B could affect endothelial cell migration in vitro. The cell scratch assay was performed using immortalized human microvascular endothelial cells cultured in conditional media derived from GICs with suppression of KDM1B or miR-215. As shown in Figures 6E, 6F , S7E, and S7F, changes in miR-215 or KDM1B expression significantly altered the migratory activity of endothelial cells. Consistently, angiogenic activity in the intracranial tumors generated from GICs expressing the miR-215 sponge was significantly diminished compared with that in the scramble control group while being restored when KDM1B was knocked down in the meantime, as measured by CD31 immunostaining of the tumor sections ( Figures S7G and S7H ).
In addition, we found the expression of two enzymes catalyzing the biosynthesis of the chondroitin sulfate chain, chondroitin polymerizing factor (CHPF) and carbohydrate (chondroitin 4) sulfotransferase 11 (CHST11), induced under hypoxia mediated by miR-215-KDM1B ( Figures 6A and 6B) , suggesting a potential role of the modification process of chondroitin sulfate proteoglycan (CSPG) chain during hypoxic responses. CSPG is composed of a core protein with modification of chondroitin sulfate chains, which is a main component of the extracellular matrix (ECM). CHPF is known to transfer glucuronic acid and N-acetylgalactosamine (GalNAc) to the non-reducing end of the chondroitin polymer. CHST11 catalyzes the transfer of sul- fate to the GalNAc residue of chondroitin. To assess the potential biological impact of countering the activities of these two enzymes on the formation of the chondroitin sulfate chain, we employed the enzyme chondroitinase ABC to cleave the polysaccharide chains without affecting the core proteins. As shown in Figures 6G and 6H , reduction in the level of the chondroitin sulfate chain significantly impaired the growth and neurosphere formation by GICs under hypoxia. Taken together, these data illustrate that repression of KDM1B via enhancement of the miR-215 signal under hypoxia could activate multiple signaling pathways, which function together to mediate adaptation of GICs to the hypoxic stress.
Relationship among Expression Profiles of HIF1a, miR-215, and KDM1B Correlated with Clinical Prognosis of GBM Patients
To evaluate the clinical relevance between KDM1B expression profiles and prognosis of GBM patients, we analyzed multiple public datasets and found that expression of KDM1B was significantly down-regulated in the GBM tissues compared with normal tissues ( Figure 7A ). More importantly, low expression of KDM1B was consistently correlated with poor clinical outcome of GBM patients, based on analyses of our GBM tissue microarrays ( Figure 7B ) and two published datasets ( Figure 7C ). Finally, we investigated the clinical correlations among hypoxia, miR-215 and KDM1B by ISH and immunohistochemistry (IHC) assays on the same set of GBM tissue microarrays and GBM xenografts. As displayed in Figure 7D , miR-215 expression was correlated positively with protein levels of HIF1a and negatively with KDM1B level in the GBM specimens. An inverse correlation was consistently observed between levels of HIF1a and KDM1B in serial sections from GBM xenografts (Figure S7I) . Consequently, these results support the notion that the HIF-miR-215-KDM1B signaling pathway plays an important role in the GBM progression, likely through regulation of hypoxic adaptation of GICs.
DISCUSSION
Several miRNAs have been functionally implicated during hypoxic responses in cancer cells. In the context of GBM, for instance, miR-210 has been reported to assist cell survival in glioma cell lines (Agrawal et al., 2014; Yang et al., 2014) . As a pivotal niche for GICs, hypoxia maintains the distinct biological properties of this specific group of cells. In this report, we have combined miRNA qPCR array with an in vivo functional screen and identified miR-215 as an essential miRNA modulating the response of GICs to hypoxia. Since miR-210 was considered to be a predominant miRNA downstream of hypoxia, we have also examined its expression level and biological function in GICs under hypoxia. The level of miR-210 is not elevated consistently in GICs from multiple lines. Suppressing the function of miR-210 in GICs could not alter the intracranial GBM progression (data not shown), suggesting that miR-210 does not serve as a universal key miRNA during the hypoxic responses in GICs.
Instead, miR-215 has emerged as a critical mediator for the hypoxic adaptation of GICs. Notably, expression levels of miR-215 and KDM1B are altered by hypoxia only in GICs rather than paired non-GICs, indicating that the miR-215-KDM1B network functions specifically in the GICs to enhance their fitness in the hypoxic niche environment and that there are differential regulations of miR-215 biogenesis by hypoxia in GICs and nonGICs. One potential mechanism is that unknown factors such as specific RNA binding proteins may be required and associated with the HIF-Drosha complex under hypoxia to enhance miR-215 biogenesis specifically in GICs. In this case, either expression level of those factors or the interactions between HIF-Drosha and the unknown factors may be differentially regulated in GICs versus non-GICs. Notably, we performed miRNA profiling in the non-GICs cultured under hypoxic and normoxic conditions and found that the overall expression pattern of the 88 miRNAs in the non-GICs is strikingly different from that in the GICs under hypoxia (data not shown), although both HIF1a and HIF2a were induced in those cells, indicating that mechanisms regulating the general miRNA biogenesis pathway by hypoxia might be different in GICs versus non-GICs. The differential responses to hypoxia and the underlying regulatory mechanisms between GICs and non-GICs remain to be further investigated. Because of the initial observations on the potential biological impact and regulatory mode of biogenesis, we focused on miR-215 in the current study. In the meantime, several other miRNAs including let-7i and miR-1260a shared a regulatory mode of their biogenesis similar to that of miR-215 by hypoxia in GICs. As those miRNAs were identified subsequently from the RNA sequencing after the initial characterization of miR-215, their potential roles in the GICs' responses to hypoxia still remain unknown and need to be examined in the future.
Genetic knockout of KDM1B in mice was embryonic lethal due to its critical roles in maintaining the maternal genomic imprints of specific genes (Ciccone et al., 2009) . In somatic cells, KDM1B possesses a great potential to modulate the expression of a large number of genes as an epigenetic regulator, which may help to maintain or reprogram the cellular state in response to environmental changes. Indeed, this notion is supported by our observations that multiple genes and pathways are regulated by KDM1B in GICs, which work collectively to affect different aspects of GIC responses to hypoxia and consequently assist their survival within the stress microenvironment. Among these pathways, biological processes of glucose metabolism and angiogenesis have been well explored to mediate the hypoxic responses. In this study, we have uncovered a potential role of the modification process of CSPG in hypoxia. The chondroitin sulfate chains in the ECM have been reported to bind ECM proteins and chemokines, as well as certain growth factors such as fibroblast growth factors, so as to enhance cancer cell proliferation and migration (Hirose et al., 2001; Takada et al., 2013) . Therefore, induction of the two enzymes could lead to accelerated biosynthesis of the chondroitin-4-sulfate (C4S) chain and enhanced pro-survival signal via interactions between C4S and ECM-associated growth factors. Indeed, this assumption is supported by a report demonstrating that the level of C4S is accumulated during hypoxia, which further mediates the effects of hypoxia through regulating its binding with galectin-3 in human bronchial epithelial cells (Bhattacharyya and Tobacman, 2012) . Although we have observed that disruption of the chondroitin sulfate chain by chondroitinase impairs the GIC growth under hypoxic stress, the exact activities of the chondroitin sulfate chain in affecting GIC function at the mechanistic level remain to be further explored.
As key transcriptional factors, HIFs are well known to stimulate transcription of miRNA genes, such as miR-210 (Huang et al., 2009 ). In concordance with this previous report, we also observed a transcriptional induction of miR-210 in GICs derived from one of the xenografted lines. On the other hand, studies have shown that hypoxia could affect miRNA processing at the post-transcriptional level through altering the expression level or modification of microprocessors, which are mainly HIF-indirect regulations (Bandara et al., 2014; Rupaimoole et al., 2014; Shen et al., 2013) . Here, we reveal a direct role of HIFs in mediating miRNA processing post-transcriptionally during hypoxic response. Currently two transcription factors, Smads and p53, have been shown to promote miRNA biogenesis directly through modulating the processing activity of Drosha complex on a subset of pri-miRNAs. These findings indicate that transcription factors may in general play multi-faceted functions, not only stimulating gene transcription but also being involved in the biogenesis of specific sets of miRNAs. This level of posttranscriptional regulation in miRNA biogenesis may help cells respond quickly to a specific extracellular signal in the environment via immediate production of a group of miRNAs and suppression of their mRNA targets. One question that remains to be fully answered is the detailed mechanism underlying regulation of the interaction between HIFs and the specific pri-miRNAs. Unlike Smad proteins that bind to a subset of pri-miRNAs directly through association of their DNA binding domain and consensus binding sequences embedded in the pri-miRNAs (Davis et al., 2008 (Davis et al., , 2010 , it appears that HIFs interact with the pri-miRNAs independently from their DNA binding domains, since a HIF1a mutant with mutations in its basic helix-loop-helix domain was still able to promote the incorporation of pri-miR-215 into HIF1a complex or affect the processing activity of miR-215 by Drosha (data not shown). It is possible that other domains of HIFs and/or additional RNA binding factors associated with HIFs could directly interact with pri-miRNAs, consequently conferring the specificity of the pri-miRNAs with enhanced processing activities under hypoxia.
EXPERIMENTAL PROCEDURES
GIC Isolation GBM xenografted lines (D456MG, 110040, 080695, and 080326) were isolated from patient specimen and passaged in nude mice as subcutaneous xenografts. Xenografted tumors were dissociated by the Papain Dissociation System (Worthington Biochemical). Cells were incubated with the microbead-conjugated CD133 antibody and separated by magnetic columns (Miltenyi Biotec) or with anti-human CD15 fluorescein isothiocyanate (eBioscience) and separated by the flow cytometry to enrich GICs. GICs and non-GICs were cultured as described by Wang et al. (2014b) . Within 7 days after CD133 separation, the same number of CD133 + and CD133 -cells was implanted intracranially to measure their abilities of tumor formation. Patient specimens were dissociated by the Papain Dissociation System and cultured in Neurobasal media as described by Wang et al. (2014b) to enrich GICs. GSCs (GSC20, GSC23, GSC17, and GSC11) provided by Dr. Erik Sulman were enriched and maintained as described by Bhat et al. (2013) .
Measurement of Pri-, Pre-, and Mature miRNAs Total RNA was extracted using the mirVana miRNA Isolation Kit (Ambion) and small RNAs less than 200 bp were enriched by the same kit according to the manufacturer's instructions. Total and the small RNAs were treated with DNaseI (Ambion) and reverse transcribed by Superscript III Reverse Transcriptase (Invitrogen) using gene specific RT primers (Jiang et al., 2005) . Expression of the pri-miRNAs was measured from the total RNAs while expression of the pre-miRNAs was determined from the small RNAs. Total RNA was reverse transcribed by the RT 2 miRNA First Strand Kit (Qiagen) to measure miRNA. Specific miRNA levels were measured by RT 2 qPCR primer assays (Qiagen) with RT 2 SYBR Green mastermix (Qiagen). ACTB was used as an internal control for pri-miRNAs; RNU6 was used as the control for pre-and mature miRNAs.
Statistical Analysis
Significance of Kaplan-Meier curves was tested by log-rank (Mantel-Cox) test. Assays of cell growth curve and microprocessor activity reporter were analyzed by two-way ANOVA with p values determined from test of interaction effects. Assays of miRNA expression among different time points and luciferase reporter of KDM1B 3 0 UTR were analyzed by one-way ANOVA to examine the significance comparing three groups. Expression profiles of miRNAs from the qPCR array and from GICs isolated from multiple xenografted lines were analyzed by twotailed paired t test. All other p values were determined using two-tailed unpaired Student t test. For mouse experiments, n denotes the number of mice. For cell culture assays, n denotes the number of biological replicates of a given experiment, and the same experiment was repeated multiple times. Please refer to the Supplemental information for additional Experimental Procedures.
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